Integrated Filing — IndAS
General information about company
| Scrip Code |
532296 |
| NSE Symbol |
GLENMARK |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE935A01035 |
| Name of company |
Glenmark Pharmaceuticals Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2026 |
| Date of end of financial year |
31-03-2027 |
| Date of board meeting when results were approved |
05-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
23-10-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Single segment |
| Description of single segment |
Pharmaceuticals |
| Start date and time of board meeting |
05-11-2026 13:15:00 |
| End date and time of board meeting |
05-11-2026 16:15:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
4,15,709.10 |
8,08,882.10 |
|
Other income |
9,277.80 |
24,529.50 |
|
Total income |
4,24,986.90 |
8,33,411.60 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
83,788.00 |
1,43,894.60 |
| (b) |
Purchases of stock-in-trade |
52,983.90 |
1,19,059.20 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(6,218.50) |
(7,820.50) |
| (d) |
Employee benefit expense |
1,02,764.40 |
1,96,233.90 |
| (e) |
Finance costs |
6,376.70 |
11,776.40 |
| (f) |
Depreciation, depletion and amortisation expense
|
18,041.60 |
35,359.00 |
| (f) |
Other Expenses |
| 1 |
Other expenses |
1,05,034.50 |
2,08,353.80 |
|
Total other expenses |
1,05,034.50 |
2,08,353.80 |
|
Total expenses |
3,62,770.60 |
7,06,856.40 |
| 3 |
Total profit before exceptional items and tax |
62,216.30 |
1,26,555.20 |
| 4 |
Exceptional items |
(28,387.50) |
(28,387.50) |
| 5 |
Total profit before tax |
33,828.80 |
98,167.70 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
12,799.30 |
33,881.00 |
| 8 |
Deferred tax |
(5,353.50) |
(10,379.10) |
| 9 |
Total tax expenses |
7,445.80 |
23,501.90 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
26,383.00 |
74,665.80 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
26,383.00 |
74,665.80 |
| 17 |
Other comprehensive income net of taxes |
(3,238.30) |
806.60 |
| 18 |
Total Comprehensive Income for the period |
23,144.70 |
75,472.40 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
0.00 |
0.00 |
|
Total profit or loss, attributable to non-controlling interests |
0.00 |
0.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
23,140.50 |
75,477.10 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
4.30 |
(4.70) |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
2,822.20 |
2,822.20 |
|
Face value of equity share capital |
1 |
1 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
9.35 |
26.46 |
|
Diluted earnings (loss) per share from continuing operations |
9.34 |
26.45 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
9.35 |
26.46 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
9.34 |
26.45 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2026 |
| Date of end of reporting period |
30-09-2026 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
3,30,674.10 |
|
Capital work-in-progress |
59,947.10 |
|
Investment property |
51,168.80 |
|
Goodwill |
8,470.30 |
|
Other intangible assets |
1,96,275.20 |
|
Intangible assets under development |
51,944.40 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
0.00 |
|
Non-current financial assets |
|
|
Non-current investments |
4,235.30 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
0.00 |
|
Other non-current financial assets |
|
| 1 |
Other financial assets |
6,938.40 |
|
Total of other non-current financial assets |
6,938.40 |
|
Total non-current financial assets |
11,173.70 |
|
Deferred tax assets (net) |
1,38,894.30 |
|
Other non-current assets |
|
| 1 |
Income tax assets (net) |
13,317.00 |
| 2 |
Other non-current assets |
6,763.30 |
|
Total of other non-current assets |
20,080.30 |
|
Total non-current assets |
8,68,628.20 |
| 2 |
Current assets |
|
|
Inventories |
3,74,619.20 |
|
Current financial asset |
|
|
Current investments |
0.00 |
|
Trade receivables, current |
5,49,374.20 |
|
Cash and cash equivalents |
1,28,992.90 |
|
Bank balance other than cash and cash equivalents |
77.20 |
|
Loans, current |
0.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
21,279.50 |
|
Total current financial assets |
6,99,723.80 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
|
| 1 |
Other current assets |
1,97,054.90 |
|
Total of other current assets |
1,97,054.90 |
|
Total current assets |
12,71,397.90 |
| 3 |
Non-current assets classified as held for sale |
|
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
|
|
Total assets |
21,40,026.10 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
2,822.20 |
|
Other equity |
11,18,421.40 |
|
Total equity attributable to owners of parent |
11,21,243.60 |
|
Non controlling interest |
(36.30) |
|
Total equity |
11,21,207.30 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
0.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Other financial liabilities |
97,900.00 |
| 2 |
Lease liabilities |
43,639.80 |
|
Total of other non-current financial liabilities |
1,41,539.80 |
|
Total non-current financial liabilities |
1,41,539.80 |
|
Provisions, non-current |
2,583.10 |
|
Deferred tax liabilities (net) |
2,527.20 |
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
| 1 |
Other non- current liabilities |
1,21,487.40 |
|
Total of other non-current liabilities |
1,21,487.40 |
|
Total non-current liabilities |
2,68,137.50 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
86,654.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
2,813.80 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
3,98,300.20 |
|
Total Trade payable |
4,01,114.00 |
|
Other current financial liabilities |
|
| 1 |
Lease liabilities |
10,453.20 |
| 2 |
Other financial liabilities |
35,816.20 |
|
Total of other current financial liabilities |
46,269.40 |
|
Total current financial liabilities |
5,34,037.40 |
|
Other current liabilities |
83,699.10 |
| 1 |
Other current liabilities |
83,699.10 |
|
Total of other current liabilities |
83,699.10 |
|
Provisions, current |
1,05,802.30 |
|
Current tax liabilities (Net) |
27,142.50 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
7,50,681.30 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
10,18,818.80 |
|
Total equity and liabilites |
21,40,026.10 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| Date of end of reporting
period |
30-09-2026 |
30-09-2026 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
null |
null |
|
Net Segment Asset |
null |
null |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
null |
null |
|
Net Segment Liabilities |
null |
null |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
|
Total Amount of items that will not be reclassified to profit and loss |
|
|
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
1,606.70 |
1,553.50 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
1,631.60 |
(2,360.10) |
| 5 |
Total Other comprehensive income |
(3,238.30) |
806.60 |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
98,167.70 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
11,776.40 |
|
Adjustments for decrease (increase) in inventories |
(29,720.10) |
|
Adjustments for decrease (increase) in trade receivables, current |
(56,761.90) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(51,507.50) |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(42,022.90) |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
0.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
35,359.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
532.70 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
(7,834.60) |
|
Adjustments for dividend income |
(0.80) |
|
Adjustments for interest income |
4,322.50 |
|
Adjustments for share-based payments |
1,468.10 |
|
Adjustments for fair value losses (gains) |
0.30 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
64.50 |
|
Other adjustments for non-cash items |
28,385.90 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
(1,14,581.80) |
|
Net cash flows from (used in)
operations |
(16,414.10) |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
3,917.70 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
(20,331.80) |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
813.20 |
|
Purchase of property, plant and equipment |
37,516.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.80 |
|
Dividends received |
0.00 |
|
Interest received |
4,280.20 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(214.00) |
|
Net cash flows from (used in)
investing activities |
(32,635.80) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
143.10 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
85,868.00 |
|
Repayments of borrowings |
0.00 |
|
Payments of lease liabilities |
8,653.40 |
|
Dividends paid |
7,133.70 |
|
Interest paid |
10,029.30 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
60,194.70 |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
7,227.10 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
4,294.90 |
|
Net increase (decrease) in cash
and cash equivalents |
11,522.00 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
1,17,470.90 |
|
Cash and cash equivalents cash
flow statement at end of period |
1,28,992.90 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Unaudited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
Walker Chandiok & Co LLP |
Yes |
31-05-2028 |